Related Experiment Video

Updated: Jul 25, 2025

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.5K

Correction to: Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease

    Brain Communications
    |June 26, 2023
    PubMed

    Insights

    This study corrects a previously published article DOI. The correction ensures accurate citation and referencing for future research in the field.

    Area of Science:

    • Neuroscience
    • Genetics

    Context:

    • Correction of a previously published article DOI.
    • Ensuring accurate scientific record-keeping.

    Purpose:

    • To provide the correct article identifier for citation.
    • To maintain the integrity of scientific literature.

    Summary:

    • The article DOI: 10.1093/braincomms/fcac278 has been corrected.
    • This ensures proper attribution and retrieval of the research.

    Impact:

    • Facilitates accurate referencing in neuroscience and genetics research.
    • Upholds the standards of scientific communication and reproducibility.

    More Related Videos

    Animal Models of Depression - Chronic Despair Model CDM05:47

    Animal Models of Depression - Chronic Despair Model CDM

    Published on: September 23, 2021

    7.3K
    Developing a Rat Model for Bipolar Disorder04:44

    Developing a Rat Model for Bipolar Disorder

    Published on: May 2, 2025

    364

    Related Concept Videos

    Antidepressant Drugs: MAOIs and Other Agents01:23

    Antidepressant Drugs: MAOIs and Other Agents

    Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
    279
    Antidepressant Drugs: Overview01:25

    Antidepressant Drugs: Overview

    Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
    600
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    303
    Depressive Disorders: MDD and Dysthymia01:27

    Depressive Disorders: MDD and Dysthymia

    Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
    176
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    222
    Depressive Disorders: Etiology01:27

    Depressive Disorders: Etiology

    Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
    Biological Factors in Depression
    Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
    141